Formus Labs is proud to have officially qualified as an approved supplier for Zimmer Biomet. As one of the largest manufacturers of orthopedic medical devices, Zimmer Biomet is among the global leaders in offering innovative, cutting-edge solutions for joint replacement surgeries. This qualification means that Formus Labs has been pre-vetted to supply Zimmer Biomet in any territory throughout the world.
In achieving ISO 13485 certification (known as the “world’s most popular standard for medical device quality management”) earlier this year, the Formus platform took a significant step toward achieving regulatory approval in international markets. Zimmer Biomet has since conducted an independent quality control audit to ensure the platform meets their own exemplary standards.
“While we’re currently commercially contracted with Zimmer Biomet in Australia and New Zealand, this opens the door to working with them across the U.S. and Europe down the line. We have a great working relationship and this is another exciting step forward”, enthused Formus Labs CEO, Dr. Ju Zhang.
With over 40% market share in both the hip and knee space, Zimmer Biomet is a strong fit for the Formus platform. This approval streamlines further collaborations between Formus Labs and Zimmer Biomet in other territories or across other divisions in the future.
A soft launch of the Formus platform for hip and shoulder replacements is scheduled across Q4 2020 and Q1 2021, and a tech demo of Formus Spine has recently been exhibited at the New Zealand Orthopaedic Association conference ahead of further development. We look forward to joining Zimmer Biomet in providing innovative orthopedic solutions that improve clinical practice and patient outcomes.